Lv5
860 积分 2022-07-27 加入
Notch pathway activation targets AML-initiating cell homeostasis and differentiation
1个月前
已完结
Markers of refractory primary immune thrombocytopenia
3个月前
已完结
Multicentre, randomised phaseIIIstudy of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
4个月前
已完结
Primary and secondary immune thrombocytopenia (ITP): Time for a rethink
4个月前
已完结
Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study
4个月前
已完结
The new era of primary immune thrombocytopenia management in adults: A narrative review of current and emerging treatments
4个月前
已完结
Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment
5个月前
已完结
Efficacy and safety of eltrombopag in combination with dexamethasone as first‐line treatment in adult patients with newly diagnosed immune thrombocytopenia
5个月前
已完结
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists
5个月前
已完结
Assessing TP53 status in human tumours to evaluate clinical outcome
8个月前
已完结
皖公网安备34019202002308
